Hear from our Chairman, Professor Sir Chris Evans, our CEO, Dr Rajan Jethwa and our Global Head of Drug Development, Professor Tobi Arkenau alongside other industry experts and get a look inside Ellipses to discover how our unique approach develops cancer medicines faster.
This feature is part of a Viewpoint docuseries committed to providing scientifically backed information on current affairs, such as healthcare. Learn more about the collaboration between Ellipses Pharma and Viewpoint here.
